# Apyx Medical Corp: filings

APYX · Nasdaq · CIK 719135 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apyx.md) · [Financials](/companies/apyx/financials.md) · [Filings](/companies/apyx/filings.md) · [Insiders](/companies/apyx/insiders.md)

## Reports and events: 288 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 208, 8-K 172, SC 13G/A 56, 10-Q 53, 3 23, DEF 14A 19, 10-K 18, SC 13G 17, SD 13, 10-K/A 9, UPLOAD 8, 4/A 7, EFFECT 7, S-3 7, S-8 7, 10-Q/A 6, 424B5 6, 8-K/A 5, CORRESP 5, 144 3, CT ORDER 3, D 3, DEFA14A 3, PRE 14A 3, S-3/A 3, SC 13D 3, SC 13D/A 3, SCHEDULE 13G/A 3, 424B7 2, 5 2, 25 1, 3/A 1, 424B1 1, 424B2 1, 424B3 1, 8-A12B/A 1, CERT 1, DEFR14A 1, NT 10-K 1, NT 10-Q 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 16:19 ET | [8-K](/filings/0001437749-26-031468.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031468 |
| 2026-08-07 | 16:00 ET | [8-K](/filings/0001493152-26-036557.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036557 |
| 2026-08-06 | 17:01 ET | [10-Q](/filings/0001437749-26-026346.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026346 |
| 2026-08-06 | 16:09 ET | [8-K](/filings/0001437749-26-026262.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026262 |
| 2026-07-24 | 17:18 ET | [8-K](/filings/0001493152-26-034619.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034619 |
| 2026-06-26 | 16:13 ET | [DEF 14A](/filings/0001437749-26-021840.md) | Proxy statement, period 2025-12-31 | 0001437749-26-021840 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001493152-26-029081.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-029081 |
| 2026-05-21 | 16:23 ET | [8-K](/filings/0001437749-26-018098.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-018098 |
| 2026-05-14 | 08:05 ET | [8-K](/filings/0001437749-26-016885.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-016885 |
| 2026-05-11 | 08:07 ET | [8-K](/filings/0001437749-26-016000.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-016000 |
| 2026-05-07 | 16:55 ET | [10-Q](/filings/0001437749-26-015652.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015652 |
| 2026-05-07 | 07:03 ET | [8-K](/filings/0001437749-26-015352.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015352 |
| 2026-03-10 | 13:11 ET | [10-K](/filings/0001437749-26-007471.md) | Annual report, period 2025-12-31 | 0001437749-26-007471 |
| 2026-03-10 | 07:01 ET | [8-K](/filings/0001437749-26-007420.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007420 |
| 2026-01-12 | 08:02 ET | [8-K](/filings/0001437749-26-001048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-001048 |
| 2025-12-12 | 16:05 ET | [8-K](/filings/0001493152-25-027481.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-027481 |
| 2025-11-19 | 16:30 ET | [8-K](/filings/0001493152-25-024279.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024279 |
| 2025-11-06 | 10:28 ET | [10-Q](/filings/0001437749-25-033499.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033499 |
| 2025-11-06 | 07:02 ET | [8-K](/filings/0001437749-25-033456.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033456 |
| 2025-08-13 | 16:00 ET | [8-K](/filings/0001641172-25-023451.md) | 5.07 Shareholder vote results | 0001641172-25-023451 |
| 2025-08-07 | 16:08 ET | [10-Q](/filings/0001437749-25-025422.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025422 |
| 2025-08-07 | 16:04 ET | [8-K](/filings/0001437749-25-025417.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025417 |
| 2025-06-25 | 09:10 ET | [DEF 14A](/filings/0001437749-25-021220.md) | Proxy statement, period 2024-12-31 | 0001437749-25-021220 |
| 2025-05-13 | 07:57 ET | [8-K](/filings/0001437749-25-016259.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016259 |
| 2025-05-08 | 12:27 ET | [10-Q](/filings/0001437749-25-015356.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015356 |
| 2025-05-08 | 06:58 ET | [8-K](/filings/0001437749-25-015231.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015231 |
| 2025-04-29 | 08:12 ET | [8-K](/filings/0001437749-25-013413.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013413 |
| 2025-03-13 | 16:06 ET | [10-K](/filings/0001437749-25-007521.md) | Annual report, period 2024-12-31 | 0001437749-25-007521 |
| 2025-03-13 | 07:00 ET | [8-K](/filings/0001437749-25-007383.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-007383 |
| 2025-02-06 | 16:14 ET | [8-K](/filings/0001437749-25-003036.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-003036 |
| 2025-01-13 | 08:00 ET | [8-K](/filings/0001437749-25-000927.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-000927 |
| 2025-01-06 | 08:00 ET | [8-K](/filings/0001437749-25-000375.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-000375 |
| 2024-11-08 | 15:38 ET | [10-Q](/filings/0001437749-24-034193.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034193 |
| 2024-11-08 | 07:29 ET | [8-K](/filings/0001493152-24-044154.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044154 |
| 2024-08-12 | 16:09 ET | [8-K](/filings/0000719135-24-000042.md) | 5.07 Shareholder vote results | 0000719135-24-000042 |
| 2024-08-08 | 17:00 ET | [10-Q](/filings/0000719135-24-000038.md) | Quarterly report, period 2024-06-30 | 0000719135-24-000038 |
| 2024-08-08 | 16:05 ET | [8-K](/filings/0000719135-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000036 |
| 2024-06-25 | 16:06 ET | [DEF 14A](/filings/0000719135-24-000032.md) | Proxy statement, period 2023-12-31 | 0000719135-24-000032 |
| 2024-05-09 | 12:14 ET | [10-Q](/filings/0000719135-24-000026.md) | Quarterly report, period 2024-03-31 | 0000719135-24-000026 |
| 2024-05-09 | 07:45 ET | [SC 13D/A](/filings/0001140361-24-025058.md) | Ownership report, active investor, amended | 0001140361-24-025058 |
| 2024-05-09 | 07:05 ET | [8-K](/filings/0000719135-24-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000024 |
| 2024-05-09 | 07:01 ET | [8-K](/filings/0000719135-24-000023.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000719135-24-000023 |
| 2024-04-05 | 09:00 ET | [SC 13D](/filings/0000921895-24-000805.md) | Ownership report, active investor | 0000921895-24-000805 |
| 2024-04-01 | 16:15 ET | [SC 13D](/filings/0001140361-24-016912.md) | Ownership report, active investor | 0001140361-24-016912 |
| 2024-03-21 | 12:08 ET | [10-K](/filings/0000719135-24-000016.md) | Annual report, period 2023-12-31 | 0000719135-24-000016 |
| 2024-03-21 | 07:06 ET | [8-K](/filings/0000719135-24-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000013 |
| 2024-02-21 | 07:33 ET | [8-K](/filings/0000719135-24-000008.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-24-000008 |
| 2024-01-22 | 08:13 ET | [8-K](/filings/0000719135-24-000005.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-24-000005 |
| 2024-01-08 | 07:01 ET | [8-K](/filings/0000719135-24-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000003 |
| 2023-11-28 | 16:57 ET | [8-K](/filings/0000719135-23-000066.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000719135-23-000066 |

Page 1 of 6. [Older](/companies/apyx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.